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Site speciﬁc mutagenesisThe mammalian Na+/H+ exchanger isoform 1 (NHE1) resides on the plasma membrane and exchanges one
intracellular H+ for one extracellular Na+. It maintains intracellular pH and regulates cell volume, and cell
functions including growth and cell differentiation. Previous structural and functional studies on TMVI
revealed several amino acids that are potentially pore lining.We examined these and other critical residues by
site-directed mutagenesis substituting Asn227→Ala, Asp, Arg; Ile233→Ala; Leu243→Ala; Glu247→Asp,
Gln; Glu248→Asp, Gln. Mutant NHE1 proteins were characterized in AP-1 cells, which do not express
endogenous NHE1. All the TMVI critical amino acids were highly sensitive to substitution and changes often
lead to a dysfunctional protein. Mutations of Asn227→Ala, Asp, Arg; Ile233→Ala; Leu243→Ala;
Glu247→Asp; Glu248→Gln yielded signiﬁcant reduction in NHE1 activity. Mutants of Asn227 demonstrated
defects in protein expression, targeting and activity. Substituting Asn227→Arg and Ile233→Ala decreased
the surface localization and expression of NHE1 respectively. The pore lining amino acids Ile233 and Leu243
were both essential for activity. Glu247 was not essential, but the size of the residue at this location was
important while the charge on residue Glu248 was more critical to NHE1 function. Limited trypsin digestion
on Leu243→Ala and Glu248→Gln revealed that they had increased susceptibility to proteolytic attack,
indicating an alteration in protein conformation. Modeling of TMVI with TMXI suggests that these TM
segments form part of the critical fold of NHE1 with Ile233 and Leu465 of TMXI forming a critical part of the
extracellular facing ion conductance pathway.yl)-5(6) carboxyﬂuorescein-
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The Na+/H+ exchangers (NHE) are membrane proteins present in
all known eukaryotic and prokaryotic cells. In mammalian cells, their
primary role is to regulate intracellular pH (pHi), maintaining
physiological pH despite acid load from cellular metabolism. Ten
mammalian Na+/H+ exchanger isoforms have been discovered. The
ﬁrst isoform, NHE1, was cloned in 1989 [1] by Pouyssegur's group and
since that time numerous functional studies have led to the
understanding of its importance in cell regulation and have identiﬁed
other NHE isoforms [2,3]. NHE1 is ubiquitously expressed on the
plasma membrane, while NHE2–NHE10 are distributed among
speciﬁc cell types, and have different kinetic characteristics, differentmembrane localization and are regulated differently [4,5]. NHE1
carries out the pHi sensitive exchange of one intracellular H+ for an
extracellular Na+. This is important because variations in pHi are
capable of disrupting normal protein folding, chemical reactions and
ion gradients [6]. In addition to pHi and volume regulation, NHE1 is
also essential for cell growth, differentiation, and migration [7–10].
Increased NHE1 levels and activity also have pathological roles in
cancer development, cardiac ischemia reperfusion injury, and cardiac
hypertrophy [11–15]. Therefore, inhibitors of NHE1 have been
investigated for their efﬁcacy of treating cancer and heart disease
[15–18].
NHE1 is composed of two domains with 815 amino acids with an
apparent molecular weight of 110 kDa in the N-linked and O-linked
glycosylated form [4,13,19]. The N-terminal domain consists of
approximately 500 residues, which form the 12 transmembrane
segments that span the plasmamembrane and arrange into a structure
for cation translocation. The latter 315 residues of NHE1 form the
cytoplasmic regulatory tail that contains phosphorylation sites, and
binding sites for PIP2, ERM (ezrin/radixin/moesin), tescalcin, 14-3-3,
carbonic anhydrase, calmodulin, calcineurin homologous protein type
1 and calcineurin homologous protein type 2 [2,3,9,10,20].
Attempts are underway to determine the high resolution crystal
structure of NHE1. However, several avenues of study have used
Table 1
Oligonucleotides used for site-directed mutagenesis of TMVI. Nucleotides mutated are
indicated in lower case, and restriction sites introduced are indicated in bold.
A
Mutation Oligonucleotide sequence Restriction
site
N227A 5′-CAACAACATCGGCCTtCTaGACgcCCTGCTCTTCGGCAGC-3′ Xba I
N227D 5′-CAACAACATCGGCCTtCTaGACgACCTGCTCTTCGGCAGC-3′ Xba I
N227R 5′-CAACAACATCGGCCTtCTaGACcgCCTGCTCTTCGGCAGC-3′ Xba I
I233A 5′-CTGCTCTTCGGatcCgcCATCTCGGCCGTGGAC-3′ Bam HI
L243A 5′-GACCCCGTGGCGGTTgccGCgGTCTTTGAGGAAATT-3′ Sac II
E247D 5′-GTTCTGGCTGTCTTTGAcGAgATTCACATCAATGAG-3′ Bsa BI
E247Q 5′-GTTCTGGCTGTCTTTcAGGAgATTCACATCAATGAG-3′ Bsa BI
E248D 5′-TCTGGCTGTCTTcGAaGAcATTCACATCAATGAG-3′ Bst BI
E248Q 5′-TCTGGCTGTCTTcGAacAAATTCACATCAATGAG-3′ Bst BI
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electron microscopy to reveal signiﬁcant insights into the secondary
and tertiary structure of NHE1 [21–24]. As part of a series of studies
analyzing the structure and function of transmembrane regions of
NHE1 [21,25,26] we recently analyzed the peptide structure of TMVI
(N227–I249) of NHE1 in DPC micelles, and analyzed the functional
contribution of amino acids of that segment by using the cysteine
scanning accessibility method [27]. Many amino acid residues of TMVI
(transmembrane segment VI) were sensitive to mutation to Cys and
reaction with external sulfhydryls indicating that TMVI was a critical
pore lining segment. Interestingly, TMVI had a structure consisting of
a helix, extended region, followed by a helix. This was similar in
structure to the critical TMIV of the Escherichia coliNa+/H+ exchanger
NhaA and we proposed that it serves a similar critical role in NHE1
activity. In this study we further characterized this key transmem-
brane segment. Of the residues in TMVI that maintained sufﬁcient
NHE1 activity when substituted to Cys, the key pore lining amino
acids of TMVI were Asn227, Ile233 and Leu243. Several other residues
had partially depressed activity when substituted to cysteine
including, Glu247 and Glu248. Moreover, the Glu248→Cys mutant
was partially inhibited by MTSET treatment [27]. Here we further
characterized the functional importance of critical amino acids in
TMVI. Applying site-directed mutagenesis methods, Asn227, Ile233,
Leu243, Glu247, and Glu248 of TMVI were substituted into
Asn227→Ala, Asp, Arg; Ile233→Ala; Leu243→Ala; Glu247→Asp,
Gln; Glu248→Asp, Gln. These mutant NHE1 proteins were assessed
for their protein expression, activity, and surface localization. Limited
digestion with trypsin was used to examine protein conformational
changes caused by mutations. Additional structural modeling was
performed based on previous NMR studies of TMVI and XI to
investigate their assembly in the cation translocation pore. Our
results demonstrate that TMVI forms a critical part of the cation access
pathway along with TMXI. Asn227 and Ile233 form part of the
extracellular facing pore while Leu243, Glu247 and Glu248 form
critical parts of the intracellular fold of the coordination pathway.
2. Materials and methods
2.1. Materials
PWO DNA polymerase was purchased from Roche Applied
Science (Roche Molecular Biochemicals, Mannheim, Germany).
Restriction enzymes were obtained from New England Biolabs, Inc.
(Mississauga ON, Canada). Lipofectamine™ 2000 reagent was
purchased from Invitrogen Life Technologies (Carlsbad CA, USA).
2′,7′-bis (2-carboxyethyl)-5(6) carboxyﬂuorescein-acetoxymethyl
ester was purchased from Molecular probes, Inc. (Eugene OR, USA).
Sulpho-NHS-SS-Biotin was from Pierce Chemical Company (Rock-
ford IL, USA). Immobilized streptavidin resin, nigericin and trypsin
(phenylalanyl chloromethyl ketone-trypsin) were from Sigma-
Aldrich (St Louis MO, USA). Geneticin G418 antibiotics were
purchased from American Bioanalytical (Natick MA, USA). Cell
culture MEM alpha modiﬁcation medium was from Thermo
Scientiﬁc Hyclone (Logan UT, USA).
2.2. Site-directed mutagenesis
Silent mutation restriction enzyme sites were introduced for
selection as described earlier [23]. We used the plasmid pYN4+ as a
template, which encoded for the entire human NHE1 and a
hemagglutinin (HA) tag at the C-terminal end [23]. The HA-tagged
NHE1 functions normally as the wild type NHE1 [21]. The oligomers
for site directed mutagenesis are indicated in Table 1. Site-directed
mutagenesis was performed using PWO DNA polymerase from the
Stratagene (La Jolla, CA, USA) QuikChange™ site directedmutagenesiskit. DNA sequencing was performed at the University of Alberta,
Department of Biochemistry DNA Core Services Lab.
2.3. Cell culture and transfections
Mutant plasmids were transfected in the AP1 cell line, which does
not express endogenous active NHE1. AP-1 is a mutant cell line
derived from Chinese hamster ovarian cells (CHO) by proton suicide
technique [1]. Stably transfected cells were established using
LIPOFECTAMINE™ 2000 Reagent (Invitrogen Life Technologies,
Carlsbad, CA, USA) as described earlier [21]. pYN4+ plasmid encoded
a neomycin resistance gene, which allowed the selection of
transfected cells using geneticin (G418) antibiotics. Stable cell lines
for experiments were regularly re-established from frozen stocks at
passage numbers between 5 and 11.
2.4. SDS-PAGE and immunoblotting
Cells were cultured in 60 or 35 mm dishes until 80–90% conﬂuent,
and then were harvested as described earlier [26]. Growth medium
was removed by aspiration and cell monolayers were washed with
4 °C phosphate-buffered saline. Plates were kept on ice to reduce
protein degradation. RIPA Lysis buffer (1% NP-40, 0.25% sodium
deoxycholate, 0.1% Triton X-100, 5 mM EGTA, 0.1 mM phenylmethyl-
sulfonyl ﬂuoride, 0.1 mM benzamidine, protease inhibitor cocktail)
was added to AP-1 cells for 1–3 min. Cell debris were removed by
centrifugation at 14,000 rpm for 5 min at 4 °C. Supernatants were
kept in clean eppendorf tubes and they were either frozen for−80 °C
storage or prepared for subsequent trypsin treatment and SDS-PAGE.
Cell lysates containing NHE1 were resolved on 10% SDS/polyacryl-
amide gels. Proteins were transferred onto nitrocellulose membrane
(BioRad) and detected using anti-HA monoclonal antibody. The
secondary antibody was peroxidase-conjugated goat anti-mouse
antibody. NHE1 was visualized by enhanced chemiluminescence,
and X-ray ﬁlms (Fuji medical X-ray ﬁlm) were processed by Kodak X-
OMAT 2000 M35 processor. ImageJ 1.35 software (National Institutes
of Health, Bethesda, MD, USA) was used to quantify band intensities.
2.5. Cell surface expression
Targeting of NHE1 to the cell surface was examined essentially as
described earlier [21,26]. Cells were grown to 50–70% conﬂuence in
60 mm dishes. The plates were placed on ice, washed once with 4 °C
PBS followed by a second wash with 4 °C borate buffer pH9 (154 mM
NaCl, 7.2 mM KCl, 1.8 mM CaCl2, 10 mM boric acid). 3 ml of freshly
made sulpho-NHS-SS-Biotin (Pierce Chemical Company, Rockford, IL,
USA) at a concentration of 0.5 mg/ml in borate buffer was added to
each plate and cells were incubated for 30 min at 4 °C. Cells were then
washed 3 times with cold quenching buffer pH 8.3 (192 mM glycine,
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500 μl IP lysis buffer pH7.5 (1% (w/v) deoxycholic acid, 1% (w/v)
Triton X-100, 0.1% (w/v) SDS, 150 mM NaCl, 1 mM EDTA, 10 mM Tris/
Cl, 0.1 mM phenylmethylsulfonyl ﬂuoride, 0.1 mM benzamidine, and
lab-made protease inhibitor cocktail). Cell debris was removed by
centrifugation at 16,000 g at 4 °C for 20 min. Supernatants were
transferred into two equal 200 μl fractions in eppendorf tubes, to a
“Total” fraction and an “Unbound” fraction. We have found [21,26]
that bound labeled NHE1 does not reliably elute from streptavidin
resin so we examined total and unbound fractions. In the unbound
fraction, 50 μl of immobilized strepavidin resin was added to bind the
biotin labeled proteins. Unbound fractions were then incubated at
4 °C overnight with gentle rocking. Supernatants were collected the
following day by centrifugation at 16,000 g for 2 min. 25 μl of the total
fraction and 28 μl of unbound fraction were loaded on 10% acrylamide
gels for SDS-PAGE. NHE1 was detected by western blotting, and
quantiﬁed using Image J software.
2.6. Na+/H+ exchange activity
NHE1 activity was determined essentially as described earlier
[7,21]. All activity assays were performed on independently made
clones of each TMVI cysteine mutant stable cell lines using a PTI
Deltascan spectroﬂuorometer. Experiments were performed at 37 °C
and all solutions and relevant equipment were pre-warmed to 37 °C.
WT, cNHE1, and TMVI mutants were cultivated on coverslips
(Thomas® Red Label® Micro Cover Glasses) in 35 mm dishes until
more than 80% conﬂuent. Cells were then incubated in 400 μl serum free
α-MEM medium containing 1.875 μg/ml 2′,7′-bis(2-carboxyethyl)-5(6)
carboxyﬂuorescein-acetoxymethyl ester (BCECF-AM; Molecular Probes
Inc., Eugene, OR, USA) for 20 min to allowBCECF-AM topenetrate into the
cell. The coverslip was attached to a coverslip holder, placed in a cuvette
ﬁlled with 2.5 ml normal buffer pH7.3 (135 mMNaCl, 5 mMKCl, 1.8 mM
CaCl2, 1 mM MgSO4, 5.5 mM glucose, 10 mM hepes) and left in the
ﬂuorometer for 3 min. 50 μl of 2.5 M ammonium chloride was added and
the cells were incubated for another 3 min. After this time the solution
was changed to 2.5 ml sodium free buffer pH7.3 (135 mMN-methyl
glucamine, 5 mM KCl, 1.8 mM CaCl2, 1 mM MgSO4, 5.5 mM glucose,
10 mM hepes) for 30 s. This step allowed the removal of the external
ammoniumchlorideand induced transient intracellular acidiﬁcation. Cells
were then returned to normal sodium containing buffer, allowing pH
recovery via the activity ofNHE1. Eachmeasurement ofNHE1activitywas
followed by a 3 point pH calibration to calibrate the amount of
ﬂuorescence to pHi. pH calibration buffers at a pH of 6, 7, and 8 were
used (5 mM N-Methyl Glucamine, 135mM KCl, 1.8 mM CaCl2, 1 mM
MgSO4, 5.5 mM glucose, 10 mMHEPES, pH adjusted with KOH and HCl).
The ﬁrst 20 s of recovery was used to calculate the NHE1 activity.
2.7. Limited trypsin digestion
Limited trypsin digestion of the NHE1 protein was used to
determine changes in conformation of the protein as described earlier
[28]. Cell lysates were prepared as described above using RIPA lysis
buffer, with the exception that proteinase inhibitors phenylmethyl-
sulfonyl ﬂuoride, benzamidine and protease cocktail were not added.
Trypsin (phenylalanyl chloromethyl ketone-trypsin, Sigma, St., Louis,
MO) was prepared and dissolved in TE buffer. Equal amounts of
proteins (100 μg) from cell lysates were treated with trypsin at
different trypsin:protein ratios (1:1500, 1:2000, 1:2500, 1:3000) and
incubated at 37 °C for 5 min. The reaction was terminated by addition
of SDS-PAGE loading buffer followed by boiling at 100 °C for 5 min.
Samples were resolved by SDS-PAGE and NHE1 detected by western
blot analysis. Quantiﬁcation of the band intensity was done using
ImageJ 1.35 software (National Institutes of Health, Bethesda, MD,
USA). To minimize variation we compared the level of fullyglycosylated NHE1 protein in mutant proteins to that of the wild
type protein treated simultaneously and run on the same gel.
2.8. Modeling of the predicted functional assembly of NHE1
Restraints deﬁning the secondary structure of both TMVI and TMXI
were obtained from the previously published NMR structures of
synthetic peptides representing TMVI and TMXI in dodecylpho-
sphocholine micelles [25,27]. Additional restraints deﬁning the
interaction between TMVI and TMXI were measured from the three-
dimensional model of NHE1 by Landau et al. [22] which proposes that
TMVI and TMXI are equivalent to the discontinuous helices TMIV and
TMXI found in the crystal structure of NhaA [29]. All interhelical
distances between protons less than 4 Å were used. These distances
were converted to restraints with a range of 1.8–4 Å for the
calculation of the model. Calculation of the ﬁnal model structure
used the distance and dihedral restraints from the NMR structure
calculation of TMVI and TMXI combined with the interhelical distance
restraints obtained from the model of Landau et al. [22]. An ensemble
of 50 structures were calculated, from which the 25 lowest energy
structures were used to calculate an average structure. Calculation of
themodel was performed using simulated annealing in xplor-nih 2.26
[30] through the python scripting interface.
2.9. Statistical analysis
Results are shown as mean±SE and statistical signiﬁcance was
determined using a Mann–Whitney U test.
3. Results
3.1. Analysis of amino acids of TMVI critical for NHE1 activity
Wehave previously [27] demonstrated that TMVI of NHE1 is a pore
lining segment with several speciﬁc amino acids of TMVI identiﬁed as
pore lining residues and with other residues having depressed NHE1
activity when mutated to Cys. We therefore decided to further
investigate the characteristics of the critical pore lining residues
Asn227, Ile233, Leu243, and other residues (Glu247 and Glu248)
important for activity. Nine mutations of various types were made to
replace these residues in the background of wild type NHE1 protein.
Hydrophilic Asn227 was mutated to an Ala with a small side chain
group, also to a Gln with longer hydrophilic side chain, and to a
positively charged Arg. Ile233 and Leu243 were mutated to Ala to
remove the contribution of their long hydrophobic side chains.
Glu247 and Glu248 were mutated into similar charged, but smaller
Asp and to a polar Gln side chain that does not have a free carboxyl. All
TMVI mutant plasmids were successfully transfected in AP-1 cells and
the expressed NHE1 protein was detected by SDS-PAGE and
subsequent western blotting against the HA tag. Initial experiments
determined the expression levels of each TMVI mutant protein
(Fig. 1). NHE1 has two forms: the mature NHE1 is glycosylated and
has a higher molecular weight at around 105–110 kDa, whereas the
immature form of NHE1 is partially or non-glycosylated with a
molecular weight around 85–95 kDa. Both forms were present in our
stably expressing cells. Some of the mutants expressed reduced
amounts of NHE1 protein. L243A and E248Q had expression reduced
to ~90% and ~75% of control NHE1 respectively. I233A displayed the
lowest expression of NHE1 expression at only 44% of wild type.
Mutation of Asn227→Arg reduced expression of the mature form of
NHE1 drastically and the immature protein made up the majority of
NHE1 expressed. We have previously found that mutation of some
other residues of NHE1 had the same effect including the mutations
I145C, Y4554C and G459C [25].
The surface localization of TMVI mutants was investigated.
Membrane proteins are usually synthesized in the endoplasmic
Fig. 1. Characterization of expression of NHE1 mutant proteins. A. NHE1 expression
levels of mutants of critical residues in TMVI. Western blot analysis of whole cell
extracts of WT NHE1, and TMVI mutants. Each lane contained 75 g of total protein. The
speciﬁc mutations are indicated. AP1 indicates untransfected-control cell lysates. NHE1
expression levels were examined using anti-HA antibody. Numbers underneath the
lanes indicate the mean value (± SE) of the sum of densitometric scans of both 110 kDa
and 95 kDa bands relative to wild-type NHE1 for at least three experiments. * indicates
mutants with signiﬁcantly different expression than WT NHE1 at P b 0.05. B. Surface
localization of NHE1 proteins withmutations in critical residues of TMVI. Sulfo-NHS-SS-
biotin treated cells were lysed and their proteins were solubilized and subsequently
treated as described in the “Materials and Methods”. Equal samples of total lysates (T)
and unbound (representing intracellular) lysates (U) were resolved on SDS-PAGE and
probed with anti-HA antibody to identify NHE1 protein. The amount of surface localized
fully glycosylated NHE1 was calculated from densitometric analysis by taking the (total
protein) – (unbound protein)= (membrane surface localized protein). The percent of the
total NHE1 protein localized to the plasmamembrane is indicated. Results are mean± SE,
n=at least 6 experiments. * Indicates signiﬁcantly reduced plasmamembranetargeting in
comparison to wild type (WT) NHE1 (P b 0.05).
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membrane destinations. Previous studies have found that mutations
in NHE1 may interrupt the synthesis and transport network, which
causes intracellular retention of the mutant protein and is reﬂected in
impaired restoration of acidiﬁed pHi [25,31,32]. Surface targeting
experiments were carried out as described in the “Materials and
methods”. The total and unbound (intracellular) fractions of cell lysates
were examined by SDS-PAGE and western blotting, and the amount of
fully glycosylated and partially/non-glycosylated NHE1weremeasured.
The results are shown in Fig. 1B and Supplementary Table 1.
Examination of the fully glycosylated NHE1 protein demonstrated that
the amount ofNHE1 targeted to the cell surfacedeclined signiﬁcantly for
both N227R and E248D mutants (Fig. 1B). N227R targeted to the cell
surface about half as well as the control. I233A and E248Q displayed
~20%higher localization ofmature glycosylatedNHE1protein to the cellsurface. There was also a ~10% signiﬁcant reduction in the glycosylated
form of the E248D mutant on the plasma membrane. The mature fully
glycosylated NHE1 protein generally targeted to themembrane surface,
whereas the immature partially glycosylated NHE1 largely remained
mainly intracellular (Supplementary Table 1). However signiﬁcant
amounts of partially- or unglycosylated NHE1 proteinwere also present
on the cell surface similar to results we have observed earlier [27].
Examination of the individual plasma membrane targeting of the fully
glycosylated and partially or de-glycosylated forms of the mutants
showed that targetingwas impaired in several other cases, this included
in all Asn227mutants and in L243AandE248D(SupplementaryTable1).
The cation transport activity of NHE1 TMVI mutant stable cell lines
was examined by assessing their ability to recover from a transient
intracellular acidiﬁcation. The results are shown in Fig. 2. Fig. 2A
illustrates an example of a time course of transient intracellular
acidiﬁcations followed by recoveries. The graph in Fig. 2B indicates the
uncorrected NHE1 activities in black bars and hatched bars are
activities normalized with expression levels and levels of surface
localization of the mature form of NHE1. Supplementary Table 1
illustrates the raw NHE1 activities prior to correction with protein
expression levels and surface expression. Somemutant NHE1 proteins
had nearly no signs of pHi recovery after intracellular acidiﬁcation
(N227R, I233A, and L243A). N227A exhibited ~75% of control activity.
N227D and E248Q had less than 40% of control activity. Correcting the
raw activities for protein expression and localization, did not revert
activity back to wild type NHE1 levels indicating that the effect of the
mutations on activity were due to effects on actual activity of the
NHE1 proteins, and not due to aberrant targeting or expression levels.
Of the nine TMVI mutations four residues, I233A, L243A, E247D,
and E248Q were chosen for further investigation to determine the
nature of the defect in NHE1 activity. Limited trypsin digestions were
carried out to determine if there were changes in protein conforma-
tion [28,33]. Cell lysates were treated with trypsin for 5 min and at
different ratios of trypsin:protein (1:1500 to 1:3000 as indicated) to
produce fragments of NHE1 protein. Control digestions of wild type
NHE1 protein were always done simultaneously with the mutants to
make experimental results more uniform. The results (Fig. 3A–E)
showed that therewas no signiﬁcant difference between the digestion
pattern of NHE1 control, E247D and I233A mutant proteins. E248Q
displayed a higher sensitivity to trypsin than the wild type, and most
of the immunoreactive NHE1 bands disappeared even at the lowest
trypsin:protein ratio of 1:3000. Other mutants were slightly more
susceptible to trypsin hydrolysis compared to WT NHE1. For L243A,
most of the bands were digested in the L243A mutant at 1:2000
trypsin:protein ratio treatment. There was no appearance of addi-
tional bands due to trypsin digestion. Western blot analysis was done
using the HA-tag at the C-terminal tail of NHE1.
3.2. Molecular modeling of TMVI and TMXI
NhaA, a bacterial homologue to the human Na+/H+ exchanger
NHE1, contains two discontinuous helices, TMIV and TMXI [22]. These
helices are thought to be central to the alternating-exchange
mechanism in the transporter. In the model of NHE1 developed by
Landau et al., [22] they suggested that TMVI and XI are functionally
and structurally equivalent to TMIV and XI, respectively, of NhaA. We
previously determined the structure of peptides of TMVI and TMXI
using high-resolution solution-state NMR in dodecylphosphocholine
micelles and found that TMXI of NHE1 is similar in structure to TMXI
of NhaA [25], and that TMVI of NHE1 is similar in structure to TMIV of
NhaA [27]. Both TMVI and TMXI contained two helical regions
connected by a ﬂexible, extended region, similar to the structure of
the discontinuous helices of TMIV and XI NhaA [22], suggesting we
could model our NMR structures into a similar conformation. To
generate amodel of the NMR structures of interacting TMVI and TMXI,









































































Fig. 2. Characterization of NHE1 activity of mutants of critical residues in TMVI. A. Example
of activity traces of wild type and mutant NHE1 proteins. The activity of WT NHE1 protein
is shown. For clarity, only the pHi recovery after acidosis is illustrated for the mutant
proteins N227A, I233A, and E248Q. B. Summary of NHE activity of mutant NHE1 proteins.
The activities of NHE1 WT control, and TMVI mutants were determined as described in
“Materials and methods”. The rate of recovery in WT NHE1 was set to 100% and mutants'
recovery rates were expressed as a percent of WT. Results are mean±S.E. (n=at least 6
determinations). Solid bars are NHE1 activities as measured, not corrected for the level of
protein expressed or surface targeting. Hatched bars indicate NHE1 activity corrected for
expression levels and surface targeting. * indicates uncorrected TMVImutant activities that
are signiﬁcantly lower than that of WT NHE1 at Pb0.05.
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Restraints deﬁning the structure of each of the TMs were deﬁned by
the previously published NMR distance and dihedral restraints
[25,27]. Restraints for the interaction between the TMs were obtained
from the Landau model [22], with inter-TM proton-proton distances
less than 4 Å set as distance restraints with a range of 1.8–4 Å. These
restraints were combined and used to generate 50 structures. An
average structure calculated from the 25 lowest energy structures is
shown in Fig. 4A.
The secondary structures of TMVI and TMXI in this model are the
same as in the NMR structures. TMVI consists of two helical regions, at
residues 229–236 and 239–250, separated by a short extended region
at residues 237–238. Residues 223–228 are ﬂexible in the model as in
the NMR structure. TMXI has a similar structure, with two helicalregions at residues 447–454 and 460–471, with an extended region at
residues 455–459. The orientation of the helices in TMVI is also
approximately the same as the earlier published NMR structure [27],
with the two helical regions at right angles to each other. TMXI, which
had much variability in the orientation of its helices in the NMR
structure [25], also adopts a right angled conformation, likely
adopting to the conformation of TMVI.
TMVI and TMXI from the model of Landau et al. [22] are shown in
Fig. 4B. The helical regions for TMXI in the Landau model are almost
the same as the NMRmodel (residues 448–454 and 460–470). The N-
terminal helix in TMVI is different. Residues 227–232 form a helix,
while 233–236 form a distorted helix. This difference in structure
results in many restraint violations in this region in the NMR model
shown in Fig. 4A. In the C-terminal helix, residues 240–246 in the
Landau model are helical, making this shorter than in the NMR based
model. The lysine tags in the NMR based model are not present in the
native protein structure or in the model of Landau et al. [22]. In Fig. 4B
it can be seen that the axes of the C-terminal helices of TMVI and TMXI
are parallel, while in Fig. 4A they are tilted away from vertical,
towards the N-terminal helices of TMVI and TMXI. The interhelical
restraints result in the orientation of side chains in the interface of the
NMR model to be generally similar in the Landau model, while the
orientation of side chains away from the interface tends towards the
results obtained with NMR measurements.
We examined the relative position of the mutated amino acids of
TMVI in two model structures of TMVI. The amino acids mutated in
this study are indicated. In Fig. 4A, Asn227 which was essential for
activity, is on the extracellular face of the membrane, possibly on the
extracellular loop, and could be part of the mouth or funnel of the
protein. Ile233 is in close association with TMXI, perhaps mediating
inter-TM associations but also possibly lining a potential pore region.
It is near to Leu465 which was a pore lining residue of TMXI [25,27].
The essential amino acid Leu243 is facing slightly away from region
between the two TM segments but points along the same face as
Leu465. Both Glu247 and Glu248 are in or near the cytosolic face of
the protein. The charge on Glu248 was essential for activity and it is
interesting that it faces away from the direction of the side chain of
Leu243. Glu247 is on a similar side as Leu243 and Leu465.
Fig. 4B illustrates a model of TMVI and TMXI based upon the
predictions of Landau et al. [22]. There are similarities and some
differences from Fig. 4A in the position of the mutated amino acids.
N227 is on the extracellular side but pointsmore away from a putative
extracellular funnel region. Ile233 is pointing more towards the inter-
TMVI-XI space, still in association with Leu465. Amino acid Leu243 is
in a similar position as in Fig. 4A. The acidic amino acids Glu247 and
Glu248 face in near opposite directions to each other. Glu247 is in a
similar position as in Fig. 4A, while the relative position of Glu248 has
changed markedly, now on the intracellular loop rather than part of
the TM helix, and it points more towards the space between the TM
segments. Both residues are on the cytosolic side of the membrane.
4. Discussion
4.1. TMVI in NHE1 function
The mechanism of Na+/H+ exchange is a question of signiﬁcant
interest both as a basic biological problem, and because of the critical
role that the NHE1 protein plays in both heart disease, cell growth and
differentiation, and in metastasis of tumor cells. In the E. coli Na+/H+
exchanger, NhaA, TM's IV and XI play a critical role in Na+/H+
exchange. Both these helices are discontinuous, interrupted by an
extended segment and the discontinuous helices form mid-membrane
dipoles. The ion binding site of NhaA is formed around the extended
segments of TMs IV and XI and includes a cluster of amino acids
(Asp164, Asp163, Asp133 and Thr132) [29,34]. We recently examined


































































2332 J. Tzeng et al. / Biochimica et Biophysica Acta 1808 (2011) 2327–2335
Fig. 4. Model of TMVI/TMXI assembly. A. Model of discontinuous helix assemblies in
NHE1 using NMR and artiﬁcial restraints. The model was generated using NMR
restraints from the structure determination of the individual helices TMVI (residues
226–250) and TMXI (residues K447-K472) combined with distances from the model
determined by Landau et al. [22]. Additional terminal lysine tags present in the TMVI
peptide structure, but not in the native sequence, are included. TMVI is shown in green,
and TMXI is shown in blue. Residues in TM VI which were mutated in this study are
labeled. The right diagram is a 180° rotation of the structure. B. Model of discontinuous
helices in NHE1 determined by Landau et al. [22]. The diagram shows the predicted
structure of TMVI and TMXI as determined by Landau et al. [22] (who describe them as
TM4 and TM11 respectively). TMVI (TM4) (residues D226-H250) is shown in green and
TMXI (TM11) (residues K447-K472) is shown in blue. Residues in TMVI which were
mutated in this study are labeled. The right diagram is a 180° rotation of the structure.
The side chain of D267 from TMVII (TM5) (residues 253–273) is shown in red.z
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Ile233 and Leu243 that are accessible from the extracellular aqueous
phase. TMVI had an architecture similar to that of TMIV of NhaA, with
two helical parts being interrupted by an extended mid membrane
segment [27]. TMIV of NHE1 had a smaller amount of similarity to TMIV
of NhaA. It had only one helical region consisting of amino acids 169–
176 [21]. We also found that another TM fragment of NHE1, TMXI, had
the helix-discontinuous region-helix structure, similar to that of TMXI of
NhaA. It also possesses pore lining residues [25].Fig. 3. Limited trypsin digestion of selected TMVI mutants. A. Western blots of WT NHE1, E24
1:1500, 1:2000, 1:2500, and1:3000as indicated. Thepattern ofNHE1digestionwasdetectedusi
results of digestion ofWTandmutantNHE1. The relative levels of fully glycosylatedNHE1were
that of the WT done simultaneously and run on the same gel.4.2. Functional analysis
In the present study, we further characterized some of the critical
amino acids of TMVI. As noted above, amino acids Asn227, Ile233 and
Leu243 were earlier shown to be pore lining amino acids, being
reactive with MTSET applied from the extracellular surface. In
addition, we earlier found that mutation of amino acids Glu247 and
Glu248 to Cys resulted in an inactive and partially active protein
respectively. The E248C mutant was also partially inhibited with
externally applied MTSET [27]. We therefore further characterized
these ﬁve amino acids in efforts to determine what role they played in
NHE1 function. Asn227 was substituted to Ala, Asp, and Arg. Ile233
and Leu243 were mutated to Ala and Glu247 and Glu248 were
mutated to Asp and Gln respectively. Asn227 is clearly an important
though not essential amino acid. None of the mutations in Asn227
were very well tolerated; N227C [27] and N227R (present study)
expressed reduced amounts of NHE1 and only the immature form of
NHE1 respectively. N227A and N227D exhibited diminished NHE1
activity and had some mistargeting. Asn contains an uncharged polar
side chain, and substitution to alanine had the least effect on NHE1
activity. When Asn227 was mutated into negatively charged Asp, the
activity of NHE1 dropped to 40% of control. Substituting positively
charged Arg for Asn227 seemed to be themost unfavorable. It resulted
in virtual elimination of activity, mistargeting of the protein and
decreased expression. The positive charge introduced by Arg could
affect sodium coordination, or could destabilize other balancing
electrostatic forces within the membrane. This could lead to
conformational changes in the protein which led to loss of production
of the fully glycosylated protein. Overall, our results with this amino
acid suggest that it is pore lining, though not absolutely essential.
Ile233 and Leu243 were also shown earlier to be important pore
lining amino acids [27]. For both of these amino acids, mutation to Ala
eliminated NHE1 activity. The decrease in activity was not accounted
for by decreased protein expression levels or by decreased targeting
to the cell surface. These results demonstrate that these amino acids
are not only pore lining, but their side chain is critical to the
maintenance of NHE1 activity. That mutation to the small uncharged
Ala caused so dramatic an effect on activity, further indicates that
these amino acids are critical in NHE1 function. Limited digestions
with trypsin did suggest a possible change in the conformation of the
I233A mutant, though this analysis was not as clear because of the
lower expression level of this protein. The L243A mutant protein did
show a slight change in accessibility to trypsin, indicating a change in
protein conformation. We suggest that mutation of this pore lining
amino acid to a smaller one affects the protein folding or stability,
which affects its accessibility to trypsin and also affects ion binding
and transport. It should be pointed out that our analysis of changes in
protein conformation was done using the C-terminal HA tag. Thus it is
possible that other changes in the N-terminal region were not
detected by our assay and new fragments not containing the HA tag
would not be detected.
Analysis of amino acids Glu247 and Glu248 was quite revealing.
We earlier demonstrated that mutation of these residues to Cys
compromised NHE1 activity and that Glu248 was at least partially
pore lining [27]. These results were intriguing and partially led to the
decision to further investigate these amino acids. Also, we have earlier
[35] suggested that the negative charge that these side chains impart,
could aid in cation coordination. Therefore, we investigated the effect
of neutralizing and modifying the charge in these positions. We
obtained different results with these two amino acids. Neutralizing
the charge on Glu247 had no effect on NHE1 activity, while changing7D, E248Q, L243A, and I233A whole cell lysates treated with trypsin:protein ratios of 0:1,
ng anti-HAantibodies. Similar resultswere reproducedat least two times. B–E. Summary of
compared forWT andmutantNHE1proteins. The levels of eachmutant are comparedwith
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changing Glu248 to Asp, had no effect on NHE1 activity while
changing to Gln, caused a precipitous decline in NHE1 activity that
was accompanied by a change in conformation of the protein. These
results demonstrate that the charge on Glu247 is unimportant in
activity, while the location and size of the amino acid is more critical.
At position 248, the charge is critical and a small change in the
position of the carboxyl group was not of great signiﬁcance. We
suggest that at amino acid 248, the carboxyl is involved in cation
coordination and/or maintenance of the coordination structure or
sphere of the NHE1 protein. A mutation at this amino acid,
neutralizing the carboxyl group, destabilized the conformation of
the protein.
4.3. Structure and function of the critical fold of NHE1
As noted above, TMVI of NHE1 resembles TMIV of NhaA, more so
than does TMIV. It also has more pore lining amino acids, as
determined by cysteine scanning mutagenesis [27]. In addition, we
earlier noted that TMXI of NHE1 is similar to TMXI of NhaA [25]. We
therefore suggest that TMVI and TMXI constitute the critical
catalytic fold of NHE1, similar to TMIV and TMXI of NhaA. Landau
et al. [22] have also suggested that TMVI and TMXI play the
equivalent role to TMIV and XI of NhaA. Their model suggests that
the amino acids of “TMVI” are actually TMIV, (the ﬁrst two TM
segments of NHE1 being removed as a signal sequence) and thus
they propose a critical TMIV–TMXI structure. Recently Nygaard et al.
[36] modeled the NHE1 protein. Their modeling suggests that TMIV
(amino acids 160–179) and TMXI are the critical fold in NHE1 and
are similar to TMIV and TMXI of NhaA. Their modeling also
suggested that Asp172 of TMIV and Arg425 of TMX have dipole
masking functions. However, we have shown that the charge on
Asp172 is unnecessary for NHE1 function [37]. Mutation of this
residue to Gln did not affect NHE1 activity and mutation to Asn only
slightly reduced activity [37]. Thus, the charge at this amino acid is
not necessary to NHE1 function and it is unlikely to have a dipole
masking function. In addition, as noted above, TMVI of NHE1 is much
more similar to TMIV of NhaA, than is TMIV of NHE1. Thus we
suggest that TMVI and TMXI are much more likely candidates for the
critical fold mediating NHE1 transport.
We therefore examined the putative structure of the TMVI and
TMXI region and the location of the critical amino acids of TMVI. The
entire structure of the NHE1 protein is unavailable; however, we have
earlier [25,27] determined the structure of peptides representing
TMVI and TMXI, and Landau et al. [22] havemodeled this region based
on comparison with NhaA. Fig. 4, depicts two models of the TMVI/XI
assembly [22,25], one based on the NMR derived structures of the TM
segments (Fig. 4A) and one from the model of Landau et al. [22]
(Fig. 4B). The positions of Asn227, Ile233, Leu243, Glu247 and Glu248
are indicated as well as some other critical nearby amino acids. In
general the overall architecture of themodel based on the determined
NMR structures and the model base on that of Landau et al. [22] are
similar but there are differences in the position of the side chains as
noted below. Both Fig. 4A and B illustrate that Asp238 lies between
the assembly of discontinuous helices TMVI/XI, and it may compen-
sate for the positive polarity contributed by the N-terminal ends.
Previously we demonstrated that substituting Asp238 with Cys
resulted in a dysfunctional NHE1 protein [27]. When considered in
the context of the whole model [22] Fig. 4B shows that the side chain
of Leu243 is pointing towards the same face of the membrane as a
putative protonation site at Asp267. This position is similar in the
empirically based NMRmodel (Fig. 4A). Asp267 is also located in close
proximity to the pore lining residues Ile233 and Leu465, which might
explain their sensitivity to mutation [22,25,27]. Given that Leu465,
Ile233 were pore lining, and that Asp267 is the putative protonation
site, it appears as though this region deﬁnes at least part of thechannel and transport site of the protein. Clearly mutation or
derivation of amino acids in this region is detrimental to the function
of NHE1 as demonstrated by mutation to amino acids Asp267, Ile233
and Leu465 [25–27]. Furthermore, studies in NhaA suggest that
movement occurs in this region during activation and transport,
which could also explain the pore accessibility we observed [38,39].
While it is uncertain which model is closer to the true structure of
NHE1, some features of each model correlate better with the data we
obtained. The charge on Glu247 was not essential while that on
Glu248was. In additionwe [27] found that when Glu248wasmutated
to Cys, reaction with MTSET partially inhibited the protein, suggesting
it is at least partially pore lining. In the NMR structure based model
Glu248 points more away from a putative coordination sphere and is
in a helical region while in the model of Landau et al. [22], Glu248 is
part of a ﬂexible loop and appears to point more towards the putative
cytoplasmic coordination sphere, which could be important in
attraction of H+'s for transport and is more in accordance with our
effects on function. Conversely, Asn227 was intolerant of mutation
and clearly an important amino acid. Mutation to a positively charged
amino acid was most detrimental, in keeping with a putative role in a
coordination sphere of a cation. In Fig. 4B Asn227 points further away
from a coordination sphere while in the NMR based model (Fig. 4A), it
is part of a ﬂexible region possibly in the extracellular loop, where it
could bemore oriented towards a putative coordination region, which
is in greater accordance with its function. Other amino acids have less
variation in their position between the twomodels. It should be noted
that overall, both models were quite similar and differences could
represent a limitation in solving the structures of single isolated
helices or different conformations of the protein during the reaction
cycle.
4.4. Conclusion
In conclusion, the critical amino acids of TMVI, Asn227, Ile233,
Leu243, Glu247 and Glu248, contribute signiﬁcantly to the normal
function of NHE1. Asn227 is essential in protein expression, proces-
sing and activity. The pore lining Ile233 may locate close to Asp267
and Leu265 and is essential for NHE1 activity, perhaps forming part of
a narrowing cation access channel or a trimming region. Leu243 is
another pore lining residue that contributes to Na+/H+ transport and
protein stability/conformation. Glu247 and Glu248 are most likely
involved in cation transport or protein stability as well, with Glu248
important in protein stability and conformational folding and the
charge on Glu248 being critical in protein function. We suggest that
TMVI makes up part of a critical fold of NHE1, similar to that which
occurs in NhaA. A full length high resolution structure of NHE1 is
desirable to conﬁrm these observations and solve the mechanism of
mammalian Na+/H+ translocation.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.05.004.
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